Peter Lee, MD
Physical Medicine & Rehabilitation · Los Angeles, CANPI 1063508786
Payments from drug & device makers
Across 20 payments — averaging $93.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$1K
- AstraZeneca$244
- Amgen$186
- Merz Pharmaceuticals, LLC$127
- MML US, Inc.$58
- American Orthodontics Corporation$33
- plus $23 from 1 others
Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$16
What the payments were for
- Food & beverage$1,871100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 8 | $1,199 |
| AstraZeneca | 2 | $244 |
| Amgen | 4 | $186 |
| Merz Pharmaceuticals, LLC | 3 | $127 |
| MML US, Inc. | 1 | $58 |
| American Orthodontics Corporation | 1 | $33 |
| Pfizer | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,871 in reported general payments places this provider in the 80th percentile of 830 physical medicine & rehabilitation providers in California.
See all physical medicine & rehabilitation providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $350 |
| Gabapentin | 26 | $90 |
| Meloxicam | 20 | $86 |
| Tramadol Hcl | 23 | $49 |
| Alendronate Sodium | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Los Angeles
- Steven SampsonLos Angeles$64K
- Kyle YangLos Angeles$39K
- Jae JungLos Angeles$34K
- Hardik ParikhLos Angeles$19K
- John ZhengLos Angeles$17K
- Ramandeep GuraiLos Angeles$14K
- Benjamin LeshinLos Angeles$11K
- Allen ChenLos Angeles$9K
- Brian SunwooLos Angeles$9K
- Ziyad AyyoubParamount$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.